2019
DOI: 10.1021/acsmedchemlett.9b00287
|View full text |Cite
|
Sign up to set email alerts
|

Fluorinated Analogues of the Histone Deacetylase Inhibitor Vorinostat (Zolinza): Validation of a Chiral Hybrid Bioisostere, BITE

Abstract: A chiral, hybrid bioisostere of the CF3 and Et groups (BITE) was installed in a series of vorinostat (Zolinza) analogues, and their histone deacetylase (HDAC) inhibitory behavior was studied relative to that of their nonfluorinated counterparts. Several of these compounds containing the 1,2-difluoroethylene unit showed in vitro potency greater than that of the clinically approved drug itself against HDAC1. This trend was found to be general with the BITE-modified HDAC inhibitors performing significantly better… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 32 publications
(16 citation statements)
references
References 44 publications
0
16
0
Order By: Relevance
“…44b With the eight hydroxamates 8a-d and 9a-d in hand, we set out to explore their inhibitory activity against HDAC1 and HDAC6 in a fluorogenic assay using ZMAL (Z-Lys(Ac)-AMC) as substrate and vorinostat (suberoylanilide hydroxamic acid, SAHA) as a control (Table 1) following our previously published protocol. 45 To our delight, all new compounds showed IC 50 values for HDAC6 in the double-or even single-digit nanomolar range comparable to those of SAHA (IC 50 : 0.031 μM). Two of the compounds (9a and 9d) showed improved HDAC6 inhibition Please do not adjust margins Please do not adjust margins compared to the control.…”
Section: Resultsmentioning
confidence: 78%
See 1 more Smart Citation
“…44b With the eight hydroxamates 8a-d and 9a-d in hand, we set out to explore their inhibitory activity against HDAC1 and HDAC6 in a fluorogenic assay using ZMAL (Z-Lys(Ac)-AMC) as substrate and vorinostat (suberoylanilide hydroxamic acid, SAHA) as a control (Table 1) following our previously published protocol. 45 To our delight, all new compounds showed IC 50 values for HDAC6 in the double-or even single-digit nanomolar range comparable to those of SAHA (IC 50 : 0.031 μM). Two of the compounds (9a and 9d) showed improved HDAC6 inhibition Please do not adjust margins Please do not adjust margins compared to the control.…”
Section: Resultsmentioning
confidence: 78%
“…To evaluate the anticancer properties of the carborane-capped HDACis, compounds 8a–d and 9a–d , as well as their phenyl analogues 10 and 11 were tested in MTT assays in the ovarian cancer cell line A2780, again using the FDA-approved HDACi vorinostat ( SAHA ) as positive control. 45 The results are summarized in Table 1 . All compounds demonstrated antiproliferative effects in the single-digit micromolar concentration range.…”
Section: Resultsmentioning
confidence: 99%
“…The inhibition of human HDAC1 and 6 was determined as previously described [ 35 ]. OptiPlate-96 black microplates (Perkin Elmer Inc., Waltham, MA, USA) were used with an assay volume of 50 µL.…”
Section: Methodsmentioning
confidence: 99%
“…Examples from this laboratory include the synthesis of a series of Vorinostat (Zolinza®) derivatives ( 45 ) containing a pendant chain capped with a vicinal difluoro motif. 72 The HDAC inhibitory behaviour of this compound set was evaluated relative to the non-fluorinated systems. 73 In all cases, the FDA approved Vorinostat (Zolinza®) was used as a control.…”
Section: Catalysis-based Strategies To Access Short (≤C 6 ) Chiral Fragmentsmentioning
confidence: 99%